Oncology & Hematology Associates of West Broward_Investigational Site Number: 8400002 — Tamarac, Florida

Oncology & Hematology Associates of West Broward_Investigational Site Number: 8400002 is a clinical research site located in Tamarac, Florida, United States 33321.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Oncology & Hematology Associates of West Broward_Investigational Site Number: 8400002 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Warm Autoimmune Hemolytic Anemia (wAIHA).

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology & Hematology Associates of West Broward_Investigational Site Number: 8400002?

Oncology & Hematology Associates of West Broward_Investigational Site Number: 8400002 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology & Hematology Associates of West Broward_Investigational Site Number: 8400002 conducted?

Oncology & Hematology Associates of West Broward_Investigational Site Number: 8400002 has 1 clinical trials on record, with 1 currently active. Their work covers Warm Autoimmune Hemolytic Anemia (wAIHA).

Is Oncology & Hematology Associates of West Broward_Investigational Site Number: 8400002 accredited by Crixeo Health?

Oncology & Hematology Associates of West Broward_Investigational Site Number: 8400002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology & Hematology Associates of West Broward_Investigational Site Number: 8400002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.